AVRX Insider Trading Activity and SEC Form 4 Filings
AVRX insider trading summary
No open-market insider purchases or sales of Avalon Pharmaceuticals Inc (AVRX) have been reported on SEC Form 4 in the past 12 months.
Latest AVRX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 23, 2008 | Kenneth C Carter | President and CEO | Buy | $2K (800 @ $2.60) |
| Jan 23, 2008 | Kenneth C Carter | President and CEO | Buy | $427 (164 @ $2.60) |
| Jan 23, 2008 | Kenneth C Carter | President and CEO | Buy | $1K (500 @ $2.49) |
| Jan 23, 2008 | Kenneth C Carter | President and CEO | Buy | $246 (100 @ $2.46) |
| Jan 23, 2008 | Kenneth C Carter | President and CEO | Buy | $2K (632 @ $2.48) |
| Jan 23, 2008 | Kenneth C Carter | President and CEO | Buy | $3K (1,036 @ $2.61) |
| Jan 23, 2008 | Kenneth C Carter | President and CEO | Buy | $249 (100 @ $2.49) |
| Jan 23, 2008 | Kenneth C Carter | President and CEO | Buy | $254 (100 @ $2.54) |
| Jan 23, 2008 | Kenneth C Carter | President and CEO | Buy | $4K (1,400 @ $2.65) |
| Jan 17, 2008 | Kenneth C Carter | President and CEO | Sell | $528 (200 @ $2.64) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.